# Pharmaloz Manufacturing Inc. – FDA Inspection, Apr 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/pharmaloz-manufacturing-inc/79ce2a80-868b-4406-aa13-eeddb6dbea6c
Source feed: FDA_Inspections

> FDA inspection 1266720 of Pharmaloz Manufacturing Inc., April 14, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266720
- Company Name: Pharmaloz Manufacturing Inc.
- Inspection Date: 2025-04-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Philadelphia District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1215503 - 2023-08-16
- [FDA Inspection 1056562 - 2018-06-21](https://www.keypedia.com/records/fda_inspections/pharmaloz-manufacturing-inc/952ed9b2-659e-4de4-872c-05f36aa21aec)
- [FDA Inspection 879146 - 2014-05-16](https://www.keypedia.com/records/fda_inspections/pharmaloz-manufacturing-inc/044a289c-e044-4b37-a1af-5e08445e0dc0)
- FDA Inspection 706645 - 2011-01-20

## Related Officers

- [Evan Tong](https://www.keypedia.com/people/evan-tong/2cd81562-886c-4672-9522-a07fb1b33ef2)

Company: https://www.keypedia.com/companies/pharmaloz-manufacturing-inc/a50b03f7-302e-439f-a910-5696712ac40a

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8
